/K I L L K I L L K I L L -- Myriad Genetics, Inc.

SALT LAKE CITY, April 7, 2014 (GLOBE NEWSWIRE) -- Please be advised that journalists and other readers should disregard the news release, "Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)" issued April 7, 2014 by Myriad Genetics, Inc., over GlobeNewswire. Copyright GlobeNewswire This announcement is distributed by NASDAQ OMX Corporate Solutions...
Comunicato Precedente

next
Comunicato Successivo

next

SALT LAKE CITY, April 7, 2014 (GLOBE NEWSWIRE) -- Please be advised that journalists and other readers should disregard the news release, "Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)" issued April 7, 2014 by Myriad Genetics, Inc., over GlobeNewswire.


Copyright GlobeNewswire


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire


[HUG#1775251]
Per maggiori informazioni
Sito Web
http://

Ufficio Stampa

 Thomson Reuters (Leggi tutti i comunicati)
3 Times Square
10036 New York, NY

Allegati
Slide ShowSlide Show
Non disponibili
;